Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Revenue	$ 727	$ 0	$ 2,162	$ 0
Cost of revenue	1,515		2,862
Gross deficit	(788)	0	(700)	0
Operating expenses:
Research and development	27,731	18,561	69,820	55,938
Acquired in-process research and development	0	0	425,070	0
Selling, general and administrative	19,582	7,778	43,095	23,053
Total operating expenses	47,313	26,339	537,985	78,991
Loss from operations	(48,101)	(26,339)	(538,685)	(78,991)
Other income (expense):
Interest income	6,726	6,523	21,000	17,588
Interest expense	(120)	0	(252)	0
Investment advisory fees	(237)	(228)	(749)	(689)
Change in fair value of warrant liability	533	383	209	260
Realized (loss) gain on marketable securities	(11)	12	(17)	(183)
Total other income (expense), net	6,891	6,690	20,191	16,976
Loss before income taxes	(41,210)	(19,649)	(518,494)	(62,015)
Provision for income taxes	0	0	0	0
Net loss	$ (41,210)	$ (19,649)	$ (518,494)	$ (62,015)
Net loss per share attributable to common stockholders, basic	$ (0.15)	$ (0.09)	$ (2.11)	$ (0.28)
Net loss per share attributable to common stockholders, diluted	$ (0.15)	$ (0.09)	$ (2.11)	$ (0.28)
Weighted average common shares outstanding, basic	273,565	218,935	245,885	218,842
Weighted average common shares outstanding, diluted	273,565	218,935	245,885	218,842
Comprehensive loss:
Net loss	$ (41,210)	$ (19,649)	$ (518,494)	$ (62,015)
Other comprehensive loss, net of taxes:
Currency translation adjustment	(742)	0	(594)	0
Change in unrealized gain on available-for-sale securities	3,389	1,097	1,794	2,228
Comprehensive loss	$ (38,563)	$ (18,552)	$ (517,294)	$ (59,787)